Correlation Between Edgewise Therapeutics and Pieris Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Pieris Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Pieris Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Pieris Pharmaceuticals, you can compare the effects of market volatilities on Edgewise Therapeutics and Pieris Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Pieris Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Pieris Pharmaceuticals.
Diversification Opportunities for Edgewise Therapeutics and Pieris Pharmaceuticals
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Edgewise and Pieris is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Pieris Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pieris Pharmaceuticals and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Pieris Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pieris Pharmaceuticals has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Pieris Pharmaceuticals go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Pieris Pharmaceuticals
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 0.72 times more return on investment than Pieris Pharmaceuticals. However, Edgewise Therapeutics is 1.39 times less risky than Pieris Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Pieris Pharmaceuticals is currently generating about 0.0 per unit of risk. If you would invest 883.00 in Edgewise Therapeutics on August 24, 2024 and sell it today you would earn a total of 2,315 from holding Edgewise Therapeutics or generate 262.17% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Pieris Pharmaceuticals
Performance |
| Timeline |
| Edgewise Therapeutics |
| Pieris Pharmaceuticals |
Edgewise Therapeutics and Pieris Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Pieris Pharmaceuticals
The main advantage of trading using opposite Edgewise Therapeutics and Pieris Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Pieris Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pieris Pharmaceuticals will offset losses from the drop in Pieris Pharmaceuticals' long position.| Edgewise Therapeutics vs. ZyVersa Therapeutics | Edgewise Therapeutics vs. Sonnet Biotherapeutics Holdings | Edgewise Therapeutics vs. Zura Bio Limited | Edgewise Therapeutics vs. Phio Pharmaceuticals Corp |
| Pieris Pharmaceuticals vs. Adaptimmune Therapeutics Plc | Pieris Pharmaceuticals vs. Mereo BioPharma Group | Pieris Pharmaceuticals vs. PDS Biotechnology Corp | Pieris Pharmaceuticals vs. Leap Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |